These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17445681)

  • 1. Bladder cancer cell invasion is enhanced by cross-talk with fibroblasts through hepatocyte growth factor.
    Wang P; Nishitani MA; Tanimoto S; Kishimoto T; Fukumori T; Takahashi M; Kanayama HO
    Urology; 2007 Apr; 69(4):780-4. PubMed ID: 17445681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
    Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
    Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
    Matsumoto-Taniura N; Matsumoto K; Nakamura T
    Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of hepatocyte growth factor in invasion of prostate cancer cell lines through tumor-stromal interaction].
    Nishimura K; Takada S; Miura H; Tsujimura A; Kitamura M; Nonomura N; Matsumiya K; Okuyama A
    Hinyokika Kiyo; 2000 Oct; 46(10):769-74. PubMed ID: 11215208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer.
    Shimabukuro K; Ichinose S; Koike R; Kubota T; Yamaguchi M; Miyasaka M; Aso T
    Gynecol Oncol; 2001 Nov; 83(2):205-15. PubMed ID: 11606073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
    Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
    Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
    Hasina R; Matsumoto K; Matsumoto-Taniura N; Kato I; Sakuda M; Nakamura T
    Br J Cancer; 1999 Aug; 80(11):1708-17. PubMed ID: 10468286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
    Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
    Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vascular endothelial growth factor and its receptor inhibitor on proliferation and invasion in bladder cancer.
    Nakanishi R; Oka N; Nakatsuji H; Koizumi T; Sakaki M; Takahashi M; Fukumori T; Kanayama HO
    Urol Int; 2009; 83(1):98-106. PubMed ID: 19641368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma.
    Kim CH; Kim J; Kahng H; Choi EC
    Ann Surg Oncol; 2007 May; 14(5):1565-74. PubMed ID: 17294073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
    Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
    Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of hepatocyte growth factor secreted from fibroblasts on the growth and invasion of scirrhous gastric cancer.
    Murakami N; Koufuji K; Shirouzu K
    Int Surg; 2001; 86(3):151-7. PubMed ID: 11996071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
    Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
    Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity.
    Bellusci S; Moens G; Gaudino G; Comoglio P; Nakamura T; Thiery JP; Jouanneau J
    Oncogene; 1994 Apr; 9(4):1091-9. PubMed ID: 8134112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor and invasion-stimulatory activity are induced in pleural fluid by surgery in lung cancer patients.
    Uchiyama A; Morisaki T; Beppu K; Kojima M; Matsunari Y; Nakatsuka A; Mizumoto K; Matsumoto K; Nakamura T; Tanaka M
    Br J Cancer; 1999 Oct; 81(4):721-6. PubMed ID: 10574262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced invasion of hormone refractory prostate cancer cells through hepatocyte growth factor (HGF) induction of urokinase-type plasminogen activator (u-PA).
    Hall CL; Tsan R; Mugnai G; Mazar A; Radinsky R; Pettaway CA
    Prostate; 2004 May; 59(2):167-76. PubMed ID: 15042617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of serum hepatocyte growth factor concentration in patients with gastric cancer is mediated by production from tumor tissue.
    Beppu K; Uchiyama A; Morisaki T; Nakamura K; Noshiro H; Matsumoto K; Nakamura T; Tanaka M; Katano M
    Anticancer Res; 2000; 20(2B):1263-7. PubMed ID: 10810432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.